ABSTRACT A Bacillus anthracis vaccine strain (Sterne), used as an attenuated laboratory comparative strain, was sequenced and analyzed. A comparison to assemblies of B. anthracis strain Sterne (NZ_CP009541 and NZ_CP009540) was performed. The lack of the pX02 plasmid and pX01 in approximately five copies was confirmed.
with a minimum variant frequency of 0.9, a minimum P value of 10e-60, and a minimum strand bias P value of 10e-5, and supported by at least five reads. A 37-fold mean coverage of the chromosome was reported with 5 million bases showing 99.99% identity with the reference sequence (5,227,150 of 5,227,496). For the chromosome, 88 variants were called, and 36 variants were predicted to affect known proteins. The plasmid pX01 yielded a 161-fold mean coverage of 181,803 bases with 99.8% identity to the reference sequence (181,233 of 181,624). For the plasmid, 13 variants were called; seven of these affected known proteins (Table 1) . With this described method and data, future B. anthracis strains can be monitored. The average chromosome/ plasmid coverage ratio suggests that the plasmid pX01 is unusually represented with approximately five copies per cell. It has been reported that sequencing coverage provides exact estimates for the plasmid copy number (8) . Since no mapping occurred on one of the pX02 reference sequences (GenBank accession number NZ_CP010794), the existence of pX02 could be excluded. Data availability. The genome sequence of B. anthracis strain Sterne 09RA8929 has been deposited in NCBI GenBank under BioSample number SAMN09635715 and 
